iPSC-Derived Immunotherapies Congress, on 18-19 October 2022 in Boston will highlight techniques used to develop safe, differentiated and efficacious therapies to pass through regulatory hurdles. This event will be your opportunity to analyze developments in bringing iPSC-derived immunotherapies from bench to bedside to deliver long-lasting, safe, effective therapeutics.
